SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-139980
Filing Date
2024-05-16
Accepted
2024-05-16 06:42:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d929103ddefa14a.htm DEFA14A 10573
2 GRAPHIC g929103g33a11.jpg GRAPHIC 419045
3 GRAPHIC g929103g33a22.jpg GRAPHIC 266769
  Complete submission text file 0001193125-24-139980.txt   956621
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39856 | Film No.: 24953528
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)